Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus

Vesicular stomatitis virus (VSV) has proven to be an effective vaccine vector for immunization against viral infection, but its potential to induce an immune response to a self-tumor antigen has not been investigated. We constructed a recombinant VSV expressing human dopachrome tautomerase (hDCT) an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bridle, Byram W, Boudreau, Jeanette E, Lichty, Brian D, Brunellière, Jérôme, Stephenson, Kyle, Koshy, Sandeep, Bramson, Jonathan L, Wan, Yonghong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2009
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835010/
https://ncbi.nlm.nih.gov/pubmed/19603003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.154
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak